Timing of levodopa therapy: evidence from MPTP-treated primates

Calcareous termite mounds in South Africa are ancient carbon reservoirs.

The Science of the total environment·2024

Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.

JAMA neurology·2021

Saline groundwater in the Buffels River catchment, Namaqualand, South Africa: A new look at an old problem.

The Science of the total environment·2020

A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.

Trials·2020

Coding accuracy for Parkinson's disease hospital admissions: implications for healthcare planning in the UK.

Public health·2017

A systematic review of interventions to reduce hospitalisation in Parkinson's disease.

Parkinsonism & related disorders·2016

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Rethinking Disease Progression in Transthyretin Amyloid Cardiomyopathy: Toward Mechanism-Specific Monitoring and Therapeutic Response Assessment.

Journal of the American College of Cardiology·2026

2026 Update on Clinical Trials in β-Thalassemia.

American journal of hematology·2026

Knowledgeable Language Models as Black-Box Optimizers for Personalized Medicine.

... International Conference on Learning Representations·2026

Artificial intelligence in trichology: A systematic review of current applications in diagnosis, severity assessment, and treatment monitoring.

Digital health·2026

Durable LVAD therapy in end-stage methamphetamine-associated heart failure: a case report of the bridge to opportunity and transplant candidacy.

European heart journal. Case reports·2026

Construction and validation of a predictive model for HBsAg loss in chronic hepatitis B patients treated with Peg-IFNα-2b.

Frontiers in cellular and infection microbiology·2026

Related Experiment Videos

Timing of levodopa therapy: evidence from MPTP-treated primates

Related Concept Videos

Calcareous termite mounds in South Africa are ancient carbon reservoirs.

Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.

Saline groundwater in the Buffels River catchment, Namaqualand, South Africa: A new look at an old problem.

A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.

Coding accuracy for Parkinson's disease hospital admissions: implications for healthcare planning in the UK.

A systematic review of interventions to reduce hospitalisation in Parkinson's disease.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Rethinking Disease Progression in Transthyretin Amyloid Cardiomyopathy: Toward Mechanism-Specific Monitoring and Therapeutic Response Assessment.

2026 Update on Clinical Trials in β-Thalassemia.

Knowledgeable Language Models as Black-Box Optimizers for Personalized Medicine.

Artificial intelligence in trichology: A systematic review of current applications in diagnosis, severity assessment, and treatment monitoring.

Durable LVAD therapy in end-stage methamphetamine-associated heart failure: a case report of the bridge to opportunity and transplant candidacy.

Construction and validation of a predictive model for HBsAg loss in chronic hepatitis B patients treated with Peg-IFNα-2b.

Related Experiment Videos

Timing of levodopa therapy: evidence from MPTP-treated primates

Related Concept Videos

Related Articles